NCT04707573View on ClinicalTrials.gov

Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 8, 2010

Primary Completion Date

September 24, 2010

Study Completion Date

September 24, 2010

Conditions
Chronic Kidney Disease
Interventions
DRUG

Vadadustat

oral capsules

Trial Locations (2)

37920

Research Site, Knoxville

55114

Research Site, Saint Paul

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY